Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A chemical genetics approach for specific differentiation of stem cells to somatic cells: a new promising therapeutical approach.

Combinatorial chemistry & high throughput screening - 1 Jan 2008

Sachinidis Agapios, Sotiriadou Isaia, Seelig Bianca, Berkessel Albrecht, Hescheler Jürgen

Abstract excerpt

Cell replacement therapy of severe degenerative diseases such as diabetes, myocardial infarction and Parkinson's disease through transplantation of somatic cells generated from embryonic stem (ES) cells is currently receiving considerable attention for the therapeutic applications. ES cells harvested from the inner cell mass (ICM) of the early embryo, can proliferate indefinitely in vitro while retaining the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemistry, Pharmaceutical
Share to Combinatorial Chemistry Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus

Share to Embryo, Mammalian

Share to Gene Targeting

Share to Myocardial Infarction

Share to Stem Cell Transplantation

Share to Stem Cells

Source

Identifiers

PMID: 18220544
DOI: 10.2174/138620708783398322

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A chemical genetics approach for specific differentiation of stem cells to somatic cells: a new promising therapeutical approach.PMID 18220544Read ↗

Embryonic stem cells: a promising tool for cell replacement therapy.Semantic proximity Read ↗

Phenotypic technologies in stem cell biology.Semantic proximity Read ↗

Embryonic stem cells: the route to experimental mammalian genetics.Semantic proximity Read ↗

Progress in the Reprogramming of Somatic CellsSemantic proximity Read ↗

Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug DiscoverySemantic proximity Read ↗

Reprogramming cell fates by small moleculesSemantic proximity Read ↗

The King is Dead, Long Live the King: Entering A New Era of Stem Cell Research and Clinical DevelopmentSemantic proximity Read ↗

Cell reprogramming: a new chemical approach to stem cell biology and tissue regeneration.Semantic proximity Read ↗

Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson’s disease could soon be hereSemantic proximity Read ↗

Small Molecules and Future Regenerative MedicineSemantic proximity Read ↗

Induced pluripotent stem cells: paths to new medicines. A catalyst for disease modelling, drug discovery and regenerative therapy.Semantic proximity Read ↗

Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industriesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.